This finding is in line with the increased metastatic growth we recently observed in MDA-MB-231 and Sum102 breast cancer cells after downregulation of TFPI [20], and provides possible candidate genes responsible for these functional effects. The gene discussed is TFPI; the disease is breast cancer.